JP2018516254A5 - - Google Patents

Download PDF

Info

Publication number
JP2018516254A5
JP2018516254A5 JP2017561653A JP2017561653A JP2018516254A5 JP 2018516254 A5 JP2018516254 A5 JP 2018516254A5 JP 2017561653 A JP2017561653 A JP 2017561653A JP 2017561653 A JP2017561653 A JP 2017561653A JP 2018516254 A5 JP2018516254 A5 JP 2018516254A5
Authority
JP
Japan
Prior art keywords
pyrimidin
amino
methanone
phenyl
benzonitrile
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2017561653A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018516254A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2016/052825 external-priority patent/WO2016193844A1/en
Publication of JP2018516254A publication Critical patent/JP2018516254A/ja
Publication of JP2018516254A5 publication Critical patent/JP2018516254A5/ja
Pending legal-status Critical Current

Links

JP2017561653A 2015-05-29 2016-05-16 バニン1酵素の阻害薬としての新規なヘテロ環化合物 Pending JP2018516254A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562167962P 2015-05-29 2015-05-29
US62/167,962 2015-05-29
US201562195005P 2015-07-21 2015-07-21
US62/195,005 2015-07-21
PCT/IB2016/052825 WO2016193844A1 (en) 2015-05-29 2016-05-16 Novel heterocyclic compounds as inhibitors of vanin-1 enzyme

Publications (2)

Publication Number Publication Date
JP2018516254A JP2018516254A (ja) 2018-06-21
JP2018516254A5 true JP2018516254A5 (https=) 2019-05-23

Family

ID=56026933

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017561653A Pending JP2018516254A (ja) 2015-05-29 2016-05-16 バニン1酵素の阻害薬としての新規なヘテロ環化合物

Country Status (5)

Country Link
US (2) US10308615B2 (https=)
EP (1) EP3303303A1 (https=)
JP (1) JP2018516254A (https=)
CA (1) CA2987179C (https=)
WO (1) WO2016193844A1 (https=)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3484876A1 (en) * 2016-07-14 2019-05-22 Pfizer Inc Novel pyrimidine carboxamides as inhibitors of vanin-1 enzyme
WO2018119142A1 (en) 2016-12-21 2018-06-28 Amgen Inc. Anti-tnf alpha antibody formulations
KR101798840B1 (ko) 2017-05-17 2017-11-17 주식회사 레고켐 바이오사이언스 신규 오토탁신 저해 화합물 및 이를 함유하는 약제학적 조성물
US10961242B2 (en) 2017-05-17 2021-03-30 Legochem Biosciences, Inc. Compounds as autotaxin inhibitors and pharmaceutical compositions comprising the same
WO2018228934A1 (en) * 2017-06-12 2018-12-20 Boehringer Ingelheim International Gmbh Heteroaromatic compounds as vanin inhibitors
US11723929B2 (en) 2017-06-13 2023-08-15 The Regents Of The University Of California Methods of improving cell-based therapy
US10702488B2 (en) * 2017-12-19 2020-07-07 Theriac Biomedical Inc. PPAR-γ activators, HDAC inhibitors and their therapeutical usages
US11497723B1 (en) * 2017-12-19 2022-11-15 Tony Antakly PPAR-gamma activators, HDAC inhibitors and their therapeutical usages
WO2019133445A1 (en) * 2017-12-28 2019-07-04 Inception Ibd, Inc. Aminothiazoles as inhibitors of vanin-1
ES2932557T3 (es) 2018-08-28 2023-01-20 Boehringer Ingelheim Int Compuestos heteroaromáticos como inhibidores de vanina
WO2020102575A1 (en) * 2018-11-16 2020-05-22 Inception Ibd, Inc. Heterocyclic aminothiazoles and uses thereof
KR20210099092A (ko) 2018-12-03 2021-08-11 베링거 인겔하임 인터내셔날 게엠베하 바닌 억제제로서의 헤테로방향족 화합물
TWI838430B (zh) * 2018-12-03 2024-04-11 德商百靈佳殷格翰國際股份有限公司 作為vanin抑制劑之雜芳族化合物
HUE070992T2 (hu) * 2018-12-03 2025-07-28 Boehringer Ingelheim Int Heteroaromás vegyületek mint vanin gátlók
WO2021092341A1 (en) * 2019-11-07 2021-05-14 Increvet, Inc. Sodium-glucose linked transporter inhibitors for the management of chronic kidney disease, hypertension, and heart failure in companion animals
WO2022081716A1 (en) * 2020-10-13 2022-04-21 Accubit LLC - Biotechnology Methods of treating iga nephropathy with thiol-containing molecules
WO2022127909A1 (zh) * 2020-12-17 2022-06-23 上海美悦生物科技发展有限公司 一种嘧啶甲酰胺类化合物及其应用
CN120247898A (zh) * 2025-03-31 2025-07-04 大连医科大学附属第二医院 一种噻吩甲酰胺类化合物及其用途

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5612359A (en) 1994-08-26 1997-03-18 Bristol-Myers Squibb Company Substituted biphenyl isoxazole sulfonamides
TW536540B (en) 1997-01-30 2003-06-11 Bristol Myers Squibb Co Endothelin antagonists: N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-N,3,3-trimethylbutanamide and N-(4,5-dimethyl-3-isoxazolyl)-2'-[(3,3-dimethyl-2-oxo-1-pyrrolidinyl)methyl]-4'-(2-oxazolyl)[1,1'-biphe
WO2000001389A1 (en) 1998-07-06 2000-01-13 Bristol-Myers Squibb Co. Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
MY125533A (en) 1999-12-06 2006-08-30 Bristol Myers Squibb Co Heterocyclic dihydropyrimidine compounds
NZ534582A (en) 2002-02-27 2006-03-31 Pfizer Prod Inc ACC inhibitors
KR100869616B1 (ko) 2004-05-12 2008-11-21 화이자 프로덕츠 인코포레이티드 프롤린 유도체 및 그의 다이펩티딜 펩티다제-iv저해제로서의 용도
JP5190448B2 (ja) 2006-04-20 2013-04-24 ファイザー・プロダクツ・インク グルコキナーゼ仲介疾患を予防および治療するための縮合フェニルアミド複素環化合物
WO2008063888A2 (en) * 2006-11-22 2008-05-29 Plexxikon, Inc. Compounds modulating c-fms and/or c-kit activity and uses therefor
EA200900613A1 (ru) 2006-11-29 2009-10-30 Пфайзер Продактс Инк. Спирокетоновые ингибиторы ацетил-коа-карбоксилаз
US20090036425A1 (en) 2007-08-02 2009-02-05 Pfizer Inc Substituted bicyclolactam compounds
WO2009143018A2 (en) * 2008-05-19 2009-11-26 Plexxikon, Inc. Compounds and methods for kinase modulation, and indications therefor
US20110009443A1 (en) 2008-05-28 2011-01-13 Kevin Daniel Freeman-Cook Pyrazolospiroketone Acetyl-Coa Carboxylase Inhibitors
WO2009144554A1 (en) 2008-05-28 2009-12-03 Pfizer, Inc. Pyrazolospiroketone acetyl-c0a carboxylase inhibitors
EP2318370A1 (en) 2008-07-29 2011-05-11 Pfizer Inc. Fluorinated heteroaryls
MY155418A (en) 2008-08-28 2015-10-15 Pfizer Dioxa-bicyclo[3.2.1]octane-2,3,4-triol derivatives
WO2010086820A1 (en) 2009-02-02 2010-08-05 Pfizer Inc. 4-amino-5-oxo-7, 8-dihydropyrimido [5,4-f] [1,4] oxazepin-6 (5h) -yl) phenyl derivatives, pharmaceutical compositions and uses thereof
US20110319379A1 (en) 2009-03-11 2011-12-29 Corbett Jeffrey W Substituted Indazole Amides And Their Use As Glucokinase Activators
MY151246A (en) 2009-03-11 2014-04-30 Pfizer Benzofuranyl derivatives
WO2010106457A2 (en) 2009-03-20 2010-09-23 Pfizer Inc. 3-oxa-7-azabicyclo[3.3.1]nonanes
CA2759843A1 (en) 2009-05-08 2010-11-10 Pfizer Inc. Gpr 119 modulators
WO2010128414A1 (en) 2009-05-08 2010-11-11 Pfizer Inc. Gpr 119 modulators
NZ596467A (en) 2009-06-05 2014-01-31 Pfizer L- ( piperidin-4-yl) -pyrazole derivatives as gpr 119 modulators
WO2011005611A1 (en) 2009-07-09 2011-01-13 Merck Sharp & Dohme Corp. Neuromedin u receptor agonists and uses thereof
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
TWI525090B (zh) 2010-04-27 2016-03-11 Mitsubishi Tanabe Pharma Corp Novel amide derivatives and their use as pharmaceuticals
AU2012255275B2 (en) 2011-05-17 2016-01-28 Plexxikon Inc. Kinase modulation and indications therefor
US20140155419A1 (en) 2011-07-29 2014-06-05 Erkan Baloglu Compounds and methods
SG10201701101YA (en) 2012-04-02 2017-04-27 Cytokinetics Inc Methods for improving diaphragm function
EP2900633A1 (en) 2012-09-25 2015-08-05 Merck Patent GmbH Alpha hydroxy amides

Similar Documents

Publication Publication Date Title
JP2018516254A5 (https=)
RU2008141509A (ru) Mglur5 модуляторы 1
JP2010513304A5 (https=)
JP2014531465A5 (https=)
RU2482111C2 (ru) Соединения, обладающие противораковой активностью
RU2009125620A (ru) Органические соединения
JP2009519967A5 (https=)
ME00427B (me) N-supstituisani hidroksipiramidinon karboksamidni inhibitori hiv integraze
RU2010110640A (ru) Соединения и композиции 5-(4-(галогеналкокси)фенил)пиримидин-2-амина в качестве ингибиторов киназ
HRP20180546T1 (hr) Supstituirani benzilindazoli za uporabu kao inhibitori bub1 kinaze za liječenje hiperproliferativnih bolesti
JP2005516934A5 (https=)
JP2019524705A5 (https=)
RU2014153626A (ru) Пиридиноновые и пиридазиноновые производные
JP2020526547A5 (https=)
HRP20141190T1 (hr) Disupstituirani derivati piridina kao antikancerogena sredstva
RU2015143517A (ru) Пиразолсодержащие соединения и их применения
JP2008507564A5 (https=)
JP2013527173A5 (https=)
JP2008525502A5 (https=)
JP2018535999A5 (https=)
AR064302A1 (es) Arilpirazoles sustitudos
HRP20140593T1 (hr) Derivati 1,3-disupstituiranih imidazolidin-2-ona kao cyp 17-inhibitori
RU2010125220A (ru) Ненуклеозидные ингибиторы обратной транскриптазы
JP2013528591A5 (https=)
HRP20200098T1 (hr) Spirociklični spojevi kao inhibitori triptofan hidroksilaze